Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...376377378379380381382383384385386...401402»
  • ||||||||||  Enrollment open:  n3 PUFA and Muscle-disuse Atrophy in Older Women (clinicaltrials.gov) -  Jun 17, 2019   
    P=N/A,  N=24, Recruiting, 
    Initiation date: Apr 2019 --> Aug 2019 Not yet recruiting --> Recruiting
  • ||||||||||  Preclinical, Journal:  Phrenic Motor Neuron Loss in Aged Rats. (Pubmed Central) -  Jun 17, 2019   
    The age-associated loss of PhMNs involved predominantly larger PhMNs. These results are consistent with an age-related denervation of larger more fatigable DIAm motor units, which are required primarily for high-force airway clearance behaviors.
  • ||||||||||  Review, Journal:  Sarcopenia and dysphagia: Position paper by four professional organizations. (Pubmed Central) -  Jun 17, 2019   
    Additionally, more discussion is required on issues such as the relationship between dysphagia and secondary sarcopenia, as well as the diagnostic criteria and means for diagnosing dysphagia caused by sarcopenia. Geriatr Gerontol Int 2019; ••: ••-••.
  • ||||||||||  Journal:  Molecular mechanism of sarcopenia (Pubmed Central) -  Jun 15, 2019   
    Geriatr Gerontol Int 2019; ••: ••-••. No abstract available
  • ||||||||||  abaloparatide (BA058) / Radius, Prolia (denosumab) / Amgen, Daiichi Sankyo, GSK, Evenity (romosozumab) / Astellas, Amgen, UCB
    Review, Journal:  Bone: best papers of the year 2017. (Pubmed Central) -  Jun 15, 2019   
    Further studies are necessary to explore the role of VDR in the progression of sarcopenia. These papers offer a hopeful outlook for a better treatment and management of patients with osteoporosis and other metabolic bone diseases anno 2018.
  • ||||||||||  Clinical, Journal:  Analysis of security by vitamin D of the elderly people. (Pubmed Central) -  Jun 15, 2019   
    Arterial hypertension, obesity of varying degrees, sarcopenia increased the risk of vitamin D deficiency in 1,15-1,17-1,2 (р<0,05-0,01) times, respectively. Oncological diseases in the anamnesis were accompanied by low parameters of vitamin 25(OH)D in blood serum (p=0,084).
  • ||||||||||  Biomarker, Journal:  CoreSlicer: a web toolkit for analytic morphomics. (Pubmed Central) -  Jun 15, 2019   
    CoreSlicer enables extraction of morphomic markers from CT images by non-technically skilled clinicians. Measurements were reproducible and accurate in relation to reference software.
  • ||||||||||  Journal:  Potential Cellular and Biochemical Mechanisms of Exercise and Physical Activity on the Ageing Process. (Pubmed Central) -  Jun 15, 2019   
    Specifically, exercise improves cardiovascular, musculoskeletal, and metabolic health through reductions in oxidative stress, chronic low-grade inflammation and modulating cellular processes within a variety of tissues. In this this chapter we will discuss the effects of acute and chronic exercise on these processes and conditions in an ageing population, and how physical activity affects our vasculature, skeletal muscle function, our immune system, and cardiometabolic risk in older adults.
  • ||||||||||  Journal:  Osteoporosis and the Ageing Skeleton. (Pubmed Central) -  Jun 15, 2019   
    Evidence associating nutritional factors, particularly calcium and vitamin D are reviewed as are the association of falls risk with fracture and the potential for interventions to prevent falls. Finally, the assessment of frailty in the oldest old, associated sarcopenia and multi-morbidity are considered in the evaluation of fall and fracture risk and the management of osteoporosis in the ninth decade of life and beyond.
  • ||||||||||  Journal:  Classifying sarcopenia: using median value or cut-off values? (Pubmed Central) -  Jun 14, 2019   
    This is a simple risk assessment tool that may help in making treatment decisions and help identifying and targeting high-risk patients with interventions to improve muscle mass prior to and following the procedures. No abstract available
  • ||||||||||  Enrollment open:  SarcObeNDS: Sarcopenic Obesity in Neurodisabilities (clinicaltrials.gov) -  Jun 12, 2019   
    P=N/A,  N=150, Enrolling by invitation, 
    The conclusion of this study will provide evidence to judge the effectiveness and safety of XLGBC on SOP. Not yet recruiting --> Enrolling by invitation
  • ||||||||||  New trial:  Muscle Capillarization and Sarcopenia (clinicaltrials.gov) -  Jun 12, 2019   
    P=N/A,  N=40, Not yet recruiting, 
  • ||||||||||  Review, Journal:  The Impact of Step Reduction on Muscle Health in Aging: Protein and Exercise as Countermeasures. (Pubmed Central) -  Jun 11, 2019   
    Periodic activity, even in small quantities, and protein supplementation may serve as effective strategies to offset the loss of muscle mass with aging, specifically during periods of inactivity. The aim of this review is to examine the recent literature encompassing SR, as a model of inactivity, and to explore the capacity of nutrition and exercise interventions to mitigate adverse physiological changes as a result of SR.
  • ||||||||||  Journal:  Identification of human skeletal muscle miRNA related to strength by high-throughput sequencing. (Pubmed Central) -  Jun 9, 2019   
    Muscle radiographic density, which is inversely proportional to myofiber lipid content Muscle attenuation was negatively correlated to let-7f-5p, miR-30d-5p and miR-125b-5p expression. In-silico analysis implicates miRNAs related to strength and muscle size in the regulation of mammalian target of rapamycin, whist whilst miRNAs related to muscle radiographic densityattenuation may have potential roles regulating the transforming growth factor- β/SMAD3 pathway.
  • ||||||||||  Review, Journal:  Role of MicroRNA-141 in the Aging Musculoskeletal System: A Current Overview. (Pubmed Central) -  Jun 9, 2019   
    One miRNA that has become of interest recently is miRNA 141. The purpose of this article is to review the current literature available on miRNA 141 and how it could play a role in osteoporosis, osteoarthritis and musculoskeletal pathology overall.
  • ||||||||||  Clinical, Journal:  Low bone mineral density in middle-aged women: a red flag for sarcopenia. (Pubmed Central) -  Jun 7, 2019   
    A BMD T-score below -1.5 suggests low muscle mass in middle-aged women, which is a central element in the diagnosis of sarcopenia. Early diagnosis provides the opportunity to introduce preventive and therapeutic options.
  • ||||||||||  Journal:  Nutrition, dietary intake, and eating behavior after liver transplantation. (Pubmed Central) -  Jun 7, 2019   
    Early diagnosis provides the opportunity to introduce preventive and therapeutic options. Understanding eating behavior after liver transplantation could be key knowledge regarding dietary intake and its impact on nutritional modifications occurring after liver transplantation.
  • ||||||||||  Journal:  Bioelectrical impedance analysis in the assessment of sarcopenia. (Pubmed Central) -  Jun 7, 2019   
    The lack of standardization of BIA use for assessing muscularity results in a wide range of sarcopenia prevalence rates among studies, even when conducted in the same population. As BIA equations and cut-off values are population and device-specific, results should be interpreted with caution when data from different devices are applied in equations or using cut-off values from a different population.
  • ||||||||||  Journal:  Vitamin D - a geriatric point of view (Pubmed Central) -  Jun 7, 2019   
    Treatment of vitamin D deficiency should be intensive and last for several months. Although the doses are high, no adverse effects were observed.